MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-DL-03-0003172
Dios Lifesciences Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹21.24 Cr
▲ 44% YoY
Net profit · FY 2024
₹83.09 Lakh
Net margin 3.9%
EBITDA · FY 2024
₹1.76 Cr
EBITDA margin 8.3%
Authorised capital
₹30 Lakh
Registered with MCA
Paid-up capital
₹19.09 Lakh
Issued & subscribed
Open charges
₹93 Lakh
Secured borrowings
Company age
15 yrs
Est. 2011
Employees · EPFO
85
Provident fund records
About Dios Lifesciences Private Limited
Data last updated:
Dios Lifesciences Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 29 July 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51397DL2011PTC223012. Its GSTIN is 07AADCD9552E1ZN (Delhi).
The company has an authorised share capital of ₹30 Lakh and a paid-up capital of ₹19.09 Lakh. It is led by directors including Manish Srivastava and Geeta Arora.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B – 1/E – 23 Mohan Co – Operative Industrial Estate, Mathura Road South East, New Delhi, Delhi, India – 110044.
As per the financials filed for FY 2024, the company reported a revenue of ₹21.24 Cr, a growth of 44% compared to the previous year. For the same year it recorded a net profit of ₹83.09 Lakh (net margin 3.9%) and EBITDA of ₹1.76 Cr (EBITDA margin 8.3%). Revenue has grown at a compounded annual rate (CAGR) of 25% over three years and 11% over five years.
The company has about 85 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Dios Lifesciences. As per MCA filings, the company has open charges of ₹93 Lakh on record. Court records list 7 cases involving the company, including 2 filed by the company and 5 filed against it; 1 case is pending.
Dios Lifesciences Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-03-0003172). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website dioslifesciences.com.
Company details
CIN U51397DL2011PTC223012
Registration Number 223012
Incorporation Date 29 July 2011
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-DL-03-0003172
Recognitions & Rankings of Dios Lifesciences
Contact details
Dios Lifesciences Private Limited's registered office is in New Delhi, Delhi. Its website is dioslifesciences.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressB – 1/E – 23 Mohan Co – Operative Industrial Estate, Mathura Road South East, New Delhi, Delhi, India – 110044
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Dios Lifesciences Private Limited, buy the company report.
Comprehensive company report
Dios Lifesciences Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Dios Lifesciences operates one associated brand: Dios Lifesciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical manufacturing, research, and distribution in India. | dioslifesciences.com |
Business activity
The main business activity of Dios Lifesciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Dios Lifesciences Private Limited, buy the company report.
Financials of Dios Lifesciences Private Limited
FY 2025 filings availableDios Lifesciences Private Limited reported revenue of ₹21.24 Cr (up 44% YoY) for FY 2024.
Revenue · FY 2024
₹21.24 Cr ▲ 44%
Net profit · FY 2024
₹83.09 Lakh margin 3.9%
EBITDA · FY 2024
₹1.76 Cr margin 8.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 44%
3 years · compounded
▲ 25%
5 years · compounded
▲ 11%
EBITDA CAGR growth
1 year
▲ 271%
3 years · compounded
▲ 61%
5 years · compounded
▲ 22%
Revenue has grown at a compounded annual rate (CAGR) of 11% over five years, including 44% growth in the latest year. EBITDA rose 271% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.76 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹83.09 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.3% | ||||
| Net Profit Margin | 3.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Dios Lifesciences Private Limited, buy the company report.
Board of directors of Dios Lifesciences Private Limited
Dios Lifesciences has 4 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manish Srivastava | Director | 30 May 2022 | 4 Years 5 Months | Current |
| Geeta Arora | Director | 22 May 2023 | 3 Years 5 Months | Current |
| Gagan Taneja | Director | 29 Jul 2011 | 15 Years 3 Months | Current |
| Jai Sheel Chabra | Director | 29 Jul 2011 | 15 Years 3 Months | Current |
Peer comparison
Dios Lifesciences Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Formulations, Lifesciences), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ce-Chem Pharmaceuticals Private Limited | ₹21.36 Cr (FY 2025) | 53.0% | Bangalore, Karnataka, India | |||
| Dexbio Pharma Private Limited | ₹21.29 Cr (FY 2025) | 17.0% | Roorkee, Uttarakhand, India | |||
| Dios Lifesciences Private Limitedthis company | ₹21.24 Cr (FY 2024) | ₹83.09 Lakh | 3.9% | 44.0% | 85 | New Delhi, Delhi, India |
| Elfin Drugs Private Limited | ₹21.23 Cr (FY 2024) | 15.0% | Mohali, Punjab, India | |||
| Marxx Pharma Private Limited | ₹21.23 Cr (FY 2024) | 682.0% | Hisar, Haryana, India | |||
| Ravi Pharmaceuticals Pvt Ltd | ₹21.23 Cr (FY 2024) | 15.0% | Khambhat, Gujarat, India | |||
| Glowsun India Labs Private Limited | ₹21.2 Cr (FY 2024) | 11.0% | Dehradun, Uttarakhand, India | |||
| Ethicare Pharmaceuticals Private Limited | ₹21.2 Cr (FY 2025) | 94.0% | Vadodara, Gujarat, India |
To see the full peer comparison of Dios Lifesciences Private Limited, buy the company report.
Auditor
Dios Lifesciences Private Limited is audited by R. P. NARANG & Co. for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| R. P. NARANG & Co. | FY 2022 | 001794N |
Shareholding
The shareholding of Dios Lifesciences Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Dios Lifesciences Private Limited, buy the company report.
Charges & borrowings
Open charges
₹93 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 31 Aug 2023 | 100772369 | Hdfc Bank Limited | ₹31 Lakh | Open | |
| 31 Aug 2023 | 100772378 | Hdfc Bank Limited | ₹31 Lakh | Open | |
| 21 Aug 2023 | 100772384 | Hdfc Bank Limited | ₹31 Lakh | Open |
Total charge records: 3 View all charges
Legal cases
Dios Lifesciences Private Limited has 7 court cases on record: 2 filed by Dios Lifesciences, 5 filed against it. 1 case is pending and 6 are disposed.
Total cases
7
Filed by the company
2
Filed against the company
5
Pending
1
Disposed
6
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 5 | 5 | 0 |
| High courts | 2 | 0 | 1 |
Cases on record (5 of 7)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Calcutta, West Bengal | Civil suit | Filed against the company by Edelweiss Retail Finance Ltd | Disposed |
| High Court of Delhi | Court case (RFA(COMM)) | Filed by the company against an individual | Pending |
| District court, South East, Delhi | Commercial suit | Filed against the company by an individual | Disposed |
| High Court of Delhi | Court case (CM(M)) | Filed by the company against an individual | Disposed |
| District court, South East, Delhi | Execution petition | Filed against the company by an individual | Disposed |
To see the full case history of Dios Lifesciences Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Dios Lifesciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Dios Lifesciences Private Limited has a workforce of 85 employees on its EPFO records as of Mar 28, 2024, across 1 active EPFO establishment.
Employee count
85
Active EPFO establishments
1
Employee growth
7.59%
GST
Dios Lifesciences has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AADCD9552E1ZN | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Dios Lifesciences Private Limited, buy the company report.
Recent activity
Dios Lifesciences Private Limited has 7 board changes on record since 2011: 4 appointments and 3 cessations. The latest: Geeta Arora was appointed as Director on 22 May 2023.
AGM
Dios Lifesciences Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Dios Lifesciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 31.00 Lakh with Charge ID 100772369 was registered on 31 Aug 2023.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 31.00 Lakh with Charge ID 100772378 was registered on 31 Aug 2023.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 31.00 Lakh with Charge ID 100772384 was registered on 21 Aug 2023.
Appointed
Geeta Arora was appointed as Director.
Ceased
Hiral Arora ceased to be Additional Director.
Ceased
Manish Srivastava ceased to be Additional Director.
Appointed
Manish Srivastava was appointed as Director.
Ceased
Neeti Srivastav ceased to be Director.
Appointed
Gagan Taneja was appointed as Director.
Appointed
Jai Sheel Chabra was appointed as Director.
1 earlier event is in the company report.
Frequently asked questions
Dios Lifesciences is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 29 July 2011 (15+ years old) and is registered under CIN U51397DL2011PTC223012.
Dios Lifesciences has 4 current directors:
- Manish Srivastava - Director
- Geeta Arora - Director
- Gagan Taneja - Director
- Jai Sheel Chabra - Director
The latest financial statements of Dios Lifesciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Dios Lifesciences is 07AADCD9552E1ZN, registered in Delhi.
The CIN (Corporate Identification Number) of Dios Lifesciences is U51397DL2011PTC223012. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dios Lifesciences has 7 court cases on record: 2 filed by the company and 5 filed against it. 1 is pending. Most are in the district courts.
Dios Lifesciences was incorporated on 29 July 2011, making it 15+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Dios Lifesciences by revenue are Ce-Chem Pharmaceuticals Private Limited, Dexbio Pharma Private Limited, Elfin Drugs Private Limited, Marxx Pharma Private Limited, Ravi Pharmaceuticals Pvt Ltd and 2 more, all in the Pharma industry (Formulations, Lifesciences), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Geeta Arora was appointed as Director on 22 May 2023. Hiral Arora ceased to be Additional Director on 26 Sep 2022. Manish Srivastava ceased to be Additional Director on 26 Sep 2022. Dios Lifesciences has 7 board changes on record in total.
Yes, Dios Lifesciences is registered as a small enterprise under Udyam registration (number: UDYAM-DL-03-0003172).
Dios Lifesciences can be reached through the website dioslifesciences.com. Its registered office is in New Delhi, Delhi, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages